Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary or Secondary Prophylactic Treatment”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableStudy completedNCT04990596
What this trial is testing

Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

Who this might be right for
Drug Resistance
Rennes University Hospital 37
Large-scale testing (Phase 3)Active Not RecruitingNCT01349881
What this trial is testing

S0820, Adenoma and Second Primary Prevention Trial

Who this might be right for
Colorectal Neoplasms
SWOG Cancer Research Network 354
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06143735
What this trial is testing

Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 99
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Post-approval studies (Phase 4)Study completedNCT00927667
What this trial is testing

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

Who this might be right for
Hemophilia A
Bayer 156
Not applicableLooking for participantsNCT07103694
What this trial is testing

I-NEED: NEw migrainE Drugs Database

Who this might be right for
Episodic MigraineChronic MigraineMedication Overuse Headache
IRCCS San Raffaele Roma 2,641
Not applicableStudy completedNCT04895098
What this trial is testing

Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD

Who this might be right for
Lipid Metabolism DisordersCardiovascular Diseases
Akrikhin 1,000
Testing effectiveness (Phase 2)Study completedNCT04339101
What this trial is testing

Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

Who this might be right for
Acute LeukemiaHematologic and Lymphocytic DisorderMyelodysplastic Syndrome+2 more
City of Hope Medical Center 59
Not applicableStudy completedNCT04893447
What this trial is testing

Suicide Prevention Among Recipients of Care

Who this might be right for
SuicideSuicide, AttemptedSuicidal Ideation+17 more
St. Luke's Health System, Boise, Idaho 1,520
Testing effectiveness (Phase 2)Looking for participantsNCT07187908
What this trial is testing

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Who this might be right for
Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Not applicableStudy completedNCT01627990
What this trial is testing

Nivestim™ in Treatment of Malignant Diseases

Who this might be right for
Solid TumourMalignant Haematological TumourPrimary or Secondary Prophylactic Treatment
Hospira, now a wholly owned subsidiary of Pfizer 386
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableUnknownNCT06343233
What this trial is testing

FAiling HearT in the Elderly (FATE) Study

Who this might be right for
Heart FailureFrailty
IRCCS Multimedica 5,000
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT04870333
What this trial is testing

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Who this might be right for
Covid19
Cambridge University Hospitals NHS Foundation Trust 2,240
1,076